XHKG
6086
, Last price
HKD
Name
Fangzhou Inc
Chart & performance
P/E
—
P/S
—
EPS
0.01
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
3.53b
+30.24%
Net income
12m
P
CFO
71m
+262.63%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Guangzhou, China, Fangzhou Inc. delivers comprehensive online chronic disease management services throughout the nation. The company leverages its dedicated digital platform to assist individuals grappling with long-term health issues like hypertension, cardiovascular, and respiratory conditions. Its mobile application facilitates a suite of "H2H" services, comprising virtual medical consultations, e-prescribing, and prescription renewal options. Furthermore, Fangzhou provides healthcare products through an online retail pharmacy and manages its own network of hospitals and brick-and-mortar pharmacies. The company was established in 2015.
Legal address
c/o Osiris International Cayman Limited
Suite #4-210, Governors Square
23 Lime Tree Bay Avenue
P.O. Box 32311
Grand Cayman KY1-1209
KY
Suite #4-210, Governors Square
23 Lime Tree Bay Avenue
P.O. Box 32311
Grand Cayman KY1-1209
KY
Headquarters
Floor 1-2, 4th Street Building
Kehui Jingu No.99
Science Avenue Luogang Science City
Huangpu District
Guangzhou 510663
CN
Kehui Jingu No.99
Science Avenue Luogang Science City
Huangpu District
Guangzhou 510663
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | |
| Income | |||||
Revenues | |||||
Cost of revenue | |||||
Unusual Expense (Income) | |||||
NOPBT | |||||
NOPBT Margin | |||||
Operating Taxes | |||||
Tax Rate | |||||
NOPAT | |||||
Net income | |||||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | |||||
| Cash flow | |||||
Cash from operating activities | |||||
CAPEX | |||||
Cash from investing activities | |||||
Cash from financing activities | |||||
FCF | |||||
| Balance | |||||
Cash | |||||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | |||||
Invested Capital | |||||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | |||||
Price | |||||
Market cap | |||||
EV | |||||
EBITDA | |||||
EV/EBITDA | |||||
Interest | |||||
Interest/NOPBT | |||||